Sertraline
Also known as: sertraline hydrochloride
Classification
Pharmaceutical
Regulatory Status
US prescription drug labeling exists for the named active ingredient. This record is not a substitute for the current label.
Sources
1
Review
n/a
Overview
Sertraline is a labeled selective serotonin reuptake inhibitor. This record does not restate psychiatric eligibility or a dose.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
Benefits
The DailyMed Zoloft label describes sertraline for labeled major depressive, obsessive-compulsive, panic, post-traumatic, social anxiety, and premenstrual dysphoric indications.
Interactions & cautions
Flagged in source data
monoamine oxidase inhibitors and other serotonergic drugs
Drug interactions
monoamine oxidase inhibitors and other serotonergic drugs — MAOIs and other serotonergic drugs can precipitate serotonin syndrome. The current label defines contraindicated combinations. (review)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw